These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11862582)

  • 1. Temporal regression of myocyte hypertrophy in hypertensive, heart failure-prone rats treated with an AT1-receptor antagonist.
    Tamura T; Said S; Andersen SM; McCune SA; Mochizuki S; Gerdes AM
    J Card Fail; 2002 Feb; 8(1):43-7. PubMed ID: 11862582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse remodeling of cardiac myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin system.
    Tamura T; Said S; Harris J; Lu W; Gerdes AM
    Circulation; 2000 Jul; 102(2):253-9. PubMed ID: 10889139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
    Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of three sites of renin-angiotensin blockade on the regression of left ventricular hypertrophy in spontaneously hypertensive rats.
    Zhang Q; Kohara K; Qui HY; Hiwada K
    Am J Ther; 1997; 4(5-6):199-202. PubMed ID: 10423611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin AT1 receptor inhibition. Effects on hypertrophic remodeling and ACE expression in rats with pressure-overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Lee MA; Weigner M; Lindpaintner K; Bishop SP; Benedict CR; Ho KK; Douglas PS; Chafizadeh E; Lorell BH
    Circulation; 1997 Mar; 95(6):1592-600. PubMed ID: 9118530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
    Yokoyama H; Averill DB; Brosnihan KB; Smith RD; Schiffrin EL; Ferrario CM
    Am J Hypertens; 2005 Jul; 18(7):922-9. PubMed ID: 16053988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats.
    Tsotetsi OJ; Woodiwiss AJ; Netjhardt M; Qubu D; Brooksbank R; Norton GR
    Hypertension; 2001 Oct; 38(4):846-51. PubMed ID: 11641297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K; Niimura S; Katoh K; Fukuchi S
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan.
    Yu G; Liang X; Xie X; Yang T; Sun M; Zhao S
    Chin Med J (Engl); 2002 Sep; 115(9):1287-91. PubMed ID: 12411096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
    Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
    Clin Cardiol; 2004 Mar; 27(3):169-73. PubMed ID: 15049387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats.
    Varo N; Etayo JC; Zalba G; Beaumont J; Iraburu MJ; Montiel C; Gil MJ; Monreal I; Díez J
    J Hypertens; 1999 Jan; 17(1):107-14. PubMed ID: 10100101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats.
    Barone FC; Coatney RW; Chandra S; Sarkar SK; Nelson AH; Contino LC; Brooks DP; Campbell WG; Ohlstein EH; Willette RN
    Cardiovasc Res; 2001 Jun; 50(3):525-37. PubMed ID: 11376628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.
    Cavasin MA; Yang XP; Liu YH; Mehta D; Karumanchi R; Bulagannawar M; Carretero OA
    J Cardiovasc Pharmacol; 2000 Oct; 36(4):472-80. PubMed ID: 11026648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model.
    Haas GJ; McCune SA; Brown DM; Cody RJ
    Am Heart J; 1995 Oct; 130(4):806-11. PubMed ID: 7572590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.